NCT01918410

Brief Summary

Contact lens induced dry eyes leads to lens intolerance and discontinuation. Incidence of dry eye in contact lens wearer is significantly higher in Asian population compared to other ethnic group considering Asian has lower tear break up time. Disruptions of tear integrity in contact lens wearer will further exacerbate the condition. Factors for successful contact lens fitting derive from the biocompatibility of lens material, lens design and stability of tear film in front of the contact lens. This study aim to investigate the efficacy of a novel daily disposable contact lens with zwitterionic material that contains alginic acid which act as a moisturizing agent. The improved lens material may likely improve the comfort and treat symptomatic wearers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2013

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 7, 2013

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

May 20, 2015

Status Verified

June 1, 2014

Enrollment Period

10 months

First QC Date

August 6, 2013

Last Update Submit

May 18, 2015

Conditions

Keywords

contact lensalginicdry eyes

Outcome Measures

Primary Outcomes (1)

  • • Difference of Visual Analogue Scale (VAS) for the ocular discomfort between control and treatment group.

    A VAS will be applied to evaluate dry eye symptoms as described by Schaumberg et al. (Schaumberg, Gulati et al. 2007). The scores will be recorded separately for frequency and severity of dry eye symptoms. The patient will be asked to check a point on a 100-mm line that corresponds to the degree of the symptom. The location of the mark made by the patient for each question will be measured in mm from the left hand side of the 100 mm line and recorded in mm. For the follow up visits, which measured the distance between the mark made by the patient and the central anchor, a negative value will be recorded if left of the anchor and a positive value if right of the anchor. A global score will be calculated by multiplying the frequency score by the severity score and taking the square root of the result (to transform back to the original scale).

    7 days

Secondary Outcomes (5)

  • Tear lipid layer thickness measurements of LipiView

    7 days

  • Schirmers I reading

    7 days

  • Tear break up time (TBUT)

    7 days

  • Corneal flourescein staining

    7 days

  • Tear proteomic analysis

    7 days

Study Arms (2)

Contact Lens with alginic acid

ACTIVE COMPARATOR
Device: Contact Lens with alginic acid

Contact lens without alginic acid

PLACEBO COMPARATOR
Device: Contact Lens without alginic acid

Interventions

Worn for 7 days, at least 8 hours a day

Contact Lens with alginic acid

Worn for 7 days, at least 8 hours a day

Contact lens without alginic acid

Eligibility Criteria

Age21 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of 21 years old and above and has full legal capacity to volunteer
  • Soft contact lens wearer
  • Willing to wear study lenses for at least 8 hours/day for 7 days
  • Reports dryness symptoms with contact lens wear on questionnaire.
  • Schirmers I with no aneasthesia of less than 10mm
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Vision correctable to 6/9 (Snellen) or better in each eye at distance with study lenses at baseline
  • Has a contact lens prescription between +4.00 to -6.00D with astigmatism \<=-1.00

You may not qualify if:

  • Requires concurrent ocular medication
  • Is participating in any concurrent clinical or research study
  • Has used Restasis® in the last 3 months
  • Wears punctal plugs fitted in the last 1 month
  • Any systemic illness which would contraindicate lens wear
  • Diabetic
  • Has had an eye injury or surgery within the last 3 months
  • Keratoconus or other corneal irregularity
  • Has had ocular surgery done within the previous 3 months
  • Active ocular surface conditions such as infection or pterygium that may affect tear film stability.
  • Is pregnant, lactating or planning a pregnancy
  • Any other specified reason as determined by clinical investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore National Eye Centre/ Singapore Eye Research Institute

Singapore, Singapore, 168751, Singapore

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Interventions

Contact Lenses

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

LensesOptical DevicesEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinician-Scientist, Senior Consultant

Study Record Dates

First Submitted

August 6, 2013

First Posted

August 7, 2013

Study Start

February 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

May 20, 2015

Record last verified: 2014-06

Locations